150 related articles for article (PubMed ID: 7909226)
21. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 plasma viraemia quantification: a non-culture measurement needed for therapeutic trials.
Semple MG; Kaye S; Loveday C; Tedder RS
J Virol Methods; 1993 Feb; 41(2):167-79. PubMed ID: 8496293
[TBL] [Abstract][Full Text] [Related]
23. Correlation between HIV provirus burden and in utero transmission.
Roques P; Marce D; Courpotin C; Mathieu FP; Herve F; Boussin FD; Narwa R; Meyohas MC; Dollfus C; Dormont D
AIDS; 1993 Nov; 7 Suppl 2():S39-43. PubMed ID: 7909225
[TBL] [Abstract][Full Text] [Related]
24. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay.
Urdea MS; Wilber JC; Yeghiazarian T; Todd JA; Kern DG; Fong SJ; Besemer D; Hoo B; Sheridan PJ; Kokka R
AIDS; 1993 Nov; 7 Suppl 2():S11-4. PubMed ID: 8161440
[TBL] [Abstract][Full Text] [Related]
25. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
[TBL] [Abstract][Full Text] [Related]
26. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
[TBL] [Abstract][Full Text] [Related]
27. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
Hatano H; Delwart EL; Norris PJ; Lee TH; Dunn-Williams J; Hunt PW; Hoh R; Stramer SL; Linnen JM; McCune JM; Martin JN; Busch MP; Deeks SG
J Virol; 2009 Jan; 83(1):329-35. PubMed ID: 18945778
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
29. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 in semen: determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations.
Ball JK; Curran R; Irving WL; Dearden AA
J Med Virol; 1999 Nov; 59(3):356-63. PubMed ID: 10502269
[TBL] [Abstract][Full Text] [Related]
31. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments.
Bruisten SM; Koppelman MH; Roos MT; Loeliger AE; Reiss P; Boucher CA; Huisman HG
AIDS; 1993 Nov; 7 Suppl 2():S15-20. PubMed ID: 8161441
[TBL] [Abstract][Full Text] [Related]
32. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
33. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
34. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection.
Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B
AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778
[TBL] [Abstract][Full Text] [Related]
35. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication.
Pernas B; Rego-Pérez I; Tabernilla A; Balboa V; Relaño S; Grandal M; Crespo M; Mena Á; Castro-Iglesias Á; Blanco FJ; Poveda E
J Antimicrob Chemother; 2017 Nov; 72(11):3159-3162. PubMed ID: 28961892
[TBL] [Abstract][Full Text] [Related]
36. Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection.
Poggi C; Profizi N; Djediouane A; Chollet L; Hittinger G; Lafeuillade A
AIDS; 1999 Jul; 13(10):1213-20. PubMed ID: 10416525
[TBL] [Abstract][Full Text] [Related]
37. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
[TBL] [Abstract][Full Text] [Related]
38. Absence of infectious human immunodeficiency virus type 1 in "natural" eccrine sweat.
Wormser GP; Bittker S; Forseter G; Hewlett IK; Argani I; Joshi B; Epstein JS; Bucher D
J Infect Dis; 1992 Jan; 165(1):155-8. PubMed ID: 1345794
[TBL] [Abstract][Full Text] [Related]
39. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.
Furtado MR; Kingsley LA; Wolinsky SM
J Virol; 1995 Apr; 69(4):2092-2100. PubMed ID: 7884855
[TBL] [Abstract][Full Text] [Related]
40. Natural history of HIV-1 cell-free viremia.
Henrard DR; Phillips JF; Muenz LR; Blattner WA; Wiesner D; Eyster ME; Goedert JJ
JAMA; 1995 Aug; 274(7):554-8. PubMed ID: 7629984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
